Mirion Technologies MIR Medical Segment — Adjusted Income Loss From Operations

Similar metrics at other companies

BSXMedSurg — Operating Income (Loss), Adjusted

$533M-0.6%

BDXMedical Essentials — Operating Income (Loss)

$574M-7.0%

NYTReportable Segment — Operating Income (Loss), Adjusted

$117.94M+27.2%

BDXMedical — Segment Operating Income as a Percent of Revenues

9%+0.1pp

CVSHealth Services — Adjusted operating income (loss)

$1.49B-7.1%

NOVTMedical Solutions — Segment Operating Income

$16.73M+19.2%

Questions, answered.

What is Mirion Technologies's medical segment — adjusted income loss from operations?

Mirion Technologies (MIR) reported medical segment — adjusted income loss from operations of -$25.4M in Q1 2026.

How has Mirion Technologies's medical segment — adjusted income loss from operations changed year-over-year?

Mirion Technologies's medical segment — adjusted income loss from operations decreased by 3.7% year-over-year, from -$24.5M to -$25.4M.

What is the long-term trend for Mirion Technologies's medical segment — adjusted income loss from operations?

Over 3 years (2022 to 2025), Mirion Technologies's medical segment — adjusted income loss from operations has grown at a -0.2% compound annual growth rate (CAGR), from -$109.7M to -$109M.

What does medical segment — adjusted income loss from operations mean?

Measures the operating profitability of the Medical segment after excluding non-recurring or non-operational items such as restructuring costs, acquisition-related expenses, or stock-based compensation. This non-GAAP metric provides a clearer view of the segment's core operational efficiency and underlying earnings power. It is frequently used by management and investors to assess the segment's sustainable performance independent of accounting anomalies.